Shenzhen Hygieia Biotechnology Co., Ltd. focuses on the R & D, production and sales of new dietary supplement raw materials. At present, we achieved the commercial production of NMN through a new enzymatic process.Since 2020, Hygieia has started the Safety Assessment of NMN raw materials, contributing to the compliance, legality and safety verification of NMN. Acute toxicology experiment - Completed, and the result is non-toxic;Bacterial reverse mutation test - In progress Mammalian erythrocyte micronucleus test - In progress In vitro mammalian cell chromosome aberration test - In progress*90 day oral toxicity test in rats - In progress Teratogenicity test in rats - In progressWe not only supply high qualified NMN raw materials, but also provide one-stop service from "Formulation" to "Global Supply chain management of NMN finished product".Now we provide high-quality NMN raw materials and finished products solutions for the global nutrition and health field
Country / Region
China
Province
Guangdong
Business Type
Manufacturer
Main Products
NMN, NAD, Nicotinamide Mononucleotide, Urolithin A, Spermidine
Year Established
2020
Employees
5 - 10 People
Turnover One Year
US$1 Million - US$2.5 Million
Main Markets
North America: 40%
Western Europe: 30%
Eastern Europe: 20%
Contact Infomation
Company Name
Shenzhen Hygieia Biotechnology Co., Ltd.
Region
Guangdong, China
Address
810, Building B, Chentian Dingjunshan Film Culture Science And Technology Creative Park, Chentian Community, Xixiang Street, Shenzhen, Guangdong, China
